Amarox

Amarox Limited is a UK subsidiary of Hetero Group, specializing in the development, licensing, and distribution of generic medicines for the National Health Service. Established in 2017, the company provides affordable, high-quality pharmaceutical products to NHS trusts, hospitals, and community pharmacies across the United Kingdom. Amarox holds over 190 marketing authorisations covering therapeutic areas including cardiovascular disease, respiratory conditions, central nervous system disorders, and anti-infective treatments.